HNN3.0

Project cooperationUpdated on 23 April 2026

LNP development

CEO at Anthelos KFT

Szeged, Hungary

About

Anthelos expertise in LNPs covers microfluidics design and production with its flexible nanoparticle generating system, LNP characterization, stability tests with its scanning nanoparticle tracking analysis system for tailored LNP formulations to optimize drug delivery for the clients’ specific therapeutic needs.

Efficiency and toxicity studies can be performed by Anthelos in primary immune cells (B-, T-cells), liver and DC cells with plate imaging and FACS analysis. Cell-type specific transfection efficiency analysis of different tissues can be done with confocal fluorescent microscopy. Anthelos applies in vivo imaging by using the company’s custom tailored in vivo imaging system with superior sensitivity for full body imaging, tissue distribution, organ- and cancer-specific targeting projects.

Anthelos is developing novel lipids and lipid additives to enhance LNP effectivity and specific targeting to liver and extrahepatic organs.

Organisation

Anthelos KFT

Company (SME)

Szeged, Hungary

Similar opportunities